Clorox Co has a consensus price target of $126.87, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, Barclays, and Citigroup on May 2, 2024, May 2, 2024, and May 1, 2024. With an average price target of $139 between Wells Fargo, Barclays, and Citigroup, there's an implied 4.53% upside for Clorox Co from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/02/2024 | Buy Now | 1.53% | Wells Fargo | Chris Carey | $140 → $135 | Maintains | Underweight | Get Alert |
05/02/2024 | Buy Now | -0.73% | Barclays | Lauren Lieberman | $136 → $132 | Maintains | Underweight | Get Alert |
05/01/2024 | Buy Now | 12.81% | Citigroup | Wendy Nicholson | $155 → $150 | Maintains | Neutral | Get Alert |
05/01/2024 | Buy Now | 19.58% | UBS | Peter Grom | $164 → $159 | Maintains | Neutral | Get Alert |
05/01/2024 | Buy Now | 18.82% | JP Morgan | Andrea Teixeira | $159 → $158 | Maintains | Neutral | Get Alert |
05/01/2024 | Buy Now | 6.79% | Evercore ISI Group | Javier Escalante | $145 → $142 | Maintains | Underperform | Get Alert |
04/17/2024 | Buy Now | 13.56% | Deutsche Bank | Stephen Powers | $155 → $151 | Maintains | Hold | Get Alert |
04/17/2024 | Buy Now | 21.83% | DA Davidson | Linda Bolton Weiser | $162 → $162 | Maintains | Neutral | Get Alert |
04/16/2024 | Buy Now | 16.57% | Citigroup | Wendy Nicholson | $165 → $155 | Maintains | Neutral | Get Alert |
04/10/2024 | Buy Now | 2.28% | Barclays | Lauren Lieberman | $148 → $136 | Maintains | Underweight | Get Alert |
04/02/2024 | Buy Now | 24.09% | Citigroup | Wendy Nicholson | $170 → $165 | Downgrade | Buy → Neutral | Get Alert |
03/26/2024 | Buy Now | 20.33% | Morgan Stanley | Dara Mohsenian | $160 → $160 | Maintains | Equal-Weight | Get Alert |
03/26/2024 | Buy Now | 9.05% | Jefferies | Kaumil Gajrawala | → $145 | Upgrade | Underperform → Hold | Get Alert |
03/01/2024 | Buy Now | 5.29% | Goldman Sachs | Bonnie Herzog | → $140 | Reinstates | → Sell | Get Alert |
02/05/2024 | Buy Now | 21.83% | DA Davidson | Linda Bolton Weiser | → $162 | Downgrade | Buy → Neutral | Get Alert |
02/02/2024 | Buy Now | 27.85% | UBS | Peter Grom | $145 → $170 | Maintains | Neutral | Get Alert |
01/18/2024 | Buy Now | 14.31% | JP Morgan | Andrea Teixeira | $145 → $152 | Maintains | Neutral | Get Alert |
01/16/2024 | Buy Now | -11.26% | Barclays | Lauren Lieberman | $115 → $118 | Maintains | Underweight | Get Alert |
12/15/2023 | Buy Now | 12.81% | B of A Securities | Anna Lizzul | $120 → $150 | Upgrade | Underperform → Neutral | Get Alert |
11/22/2023 | Buy Now | 9.05% | JP Morgan | Andrea Teixeira | $124 → $145 | Upgrade | Underweight → Neutral | Get Alert |
11/17/2023 | Buy Now | 21.83% | DA Davidson | Linda Bolton Weiser | $152 → $162 | Maintains | Buy | Get Alert |
11/13/2023 | Buy Now | -12.01% | Jefferies | Kaumil Gajrawala | → $117 | Initiates | → Underperform | Get Alert |
11/06/2023 | Buy Now | -0.73% | UBS | Peter Grom | $124 → $132 | Upgrade | Sell → Neutral | Get Alert |
11/02/2023 | Buy Now | 12.81% | Citigroup | Wendy Nicholson | $135 → $150 | Upgrade | Neutral → Buy | Get Alert |
10/12/2023 | Buy Now | -9.75% | Bernstein | Callum Elliott | → $120 | Upgrade | Underperform → Market Perform | Get Alert |
10/11/2023 | Buy Now | 1.53% | Citigroup | Wendy Nicholson | $170 → $135 | Maintains | Neutral | Get Alert |
10/05/2023 | Buy Now | -9.75% | Evercore ISI Group | Javier Escalante | $160 → $120 | Maintains | Underperform | Get Alert |
10/05/2023 | Buy Now | -6.75% | JP Morgan | Andrea Teixeira | $152 → $124 | Maintains | Underweight | Get Alert |
10/05/2023 | Buy Now | -9.75% | B of A Securities | Anna Lizzul | $145 → $120 | Maintains | Underperform | Get Alert |
10/05/2023 | Buy Now | — | Raymond James | Olivia Tong | — | Downgrade | Outperform → Market Perform | Get Alert |
The latest price target for Clorox (NYSE: CLX) was reported by Wells Fargo on May 2, 2024. The analyst firm set a price target for $135.00 expecting CLX to rise to within 12 months (a possible 1.53% upside). 39 analyst firms have reported ratings in the last year.
The latest analyst rating for Clorox (NYSE: CLX) was provided by Wells Fargo, and Clorox maintained their underweight rating.
The last upgrade for Clorox Co happened on March 26, 2024 when Jefferies raised their price target to $145. Jefferies previously had an underperform for Clorox Co.
The last downgrade for Clorox Co happened on April 2, 2024 when Citigroup changed their price target from $170 to $165 for Clorox Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Clorox, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Clorox was filed on May 2, 2024 so you should expect the next rating to be made available sometime around May 2, 2025.
While ratings are subjective and will change, the latest Clorox (CLX) rating was a maintained with a price target of $140.00 to $135.00. The current price Clorox (CLX) is trading at is $132.97, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.